Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

US-Based Axiom Seeks Hong Kong IPO to Tap China’s Biotech Boom

Bloomberg

BusinessBloomberg·Jul 21, 2026·1 min read

US-Based Axiom Seeks Hong Kong IPO to Tap China’s Biotech Boom

Axiom Biosciences is considering an initial public offering in Hong Kong, a rare move for an American biotechnology firm, and one that would help it tap China’s booming clinical development capabilities.

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

Google expands Gemini lineup with cheaper models and new Mythos rival

BusinessJul 21, 2026 · 1 min

Google expands Gemini lineup with cheaper models and new Mythos rival

Nvidia details its next-generation Vera CPU for AI, setting up challenge to AMD and Intel

BusinessJul 21, 2026 · 1 min

Nvidia details its next-generation Vera CPU for AI, setting up challenge to AMD and Intel

Carney speaks after Trump threatens new tariffs on Canadian goods

BusinessJul 21, 2026 · 1 min

Carney speaks after Trump threatens new tariffs on Canadian goods

SpaceX’s Great Unlocking Begins With $116 Billion Share Release

BusinessJul 21, 2026 · 1 min

SpaceX’s Great Unlocking Begins With $116 Billion Share Release